4th Cell Therapy for Autoimmune Disease Summit 2026
Hosted by Hanson Wade
- 1 – 3 December 2026
Add to calendar
Welcome to kongre.net - Hilton Philadelphia City Avenue, Philadelphia, United States of America
- Basic MedicineImmunologyHealth SciencesPharmacy & Pharmaceutical Sciences
Let others know you'll be there. This does not register you for the event.
Registration
Registration is handled by the organiser
Fees are listed on this page
View registration detailsKey facts
4th Cell Therapy for Autoimmune Disease Summit 2026 is a summit held 1 – 3 December 2026 in Hilton Philadelphia City Avenue, Philadelphia, United States of America, organised by Hanson Wade.
- Dates:
- 1 – 3 December 2026
- Format:
- In person
- Venue:
- Hilton Philadelphia City Avenue, Philadelphia, United States of America
- Subjects:
- Immunology, Pharmacy & Pharmaceutical Sciences
- Organiser:
- Hanson Wade
- Official website:
- cell-therapy-autoimmune-disease.com
The 4th Cell Therapy for Autoimmune Disease Summit returns to Philadelphia as the only dedicated forum uniting developers of autologous, allogeneic, and in vivo cell therapy approaches for autoimmune conditions. Bringing together pioneering leaders from biotech, pharma, and academia, the event explores the latest breakthroughs across lupus, multiple sclerosis, rheumatoid arthritis, and rare autoimmune indications. As the field advances beyond oncology toward disease-modifying immune reset, the summit addresses critical challenges in safety, scalability, durability, and commercial access through specialized content tracks and networking sessions.
Conference theme
Who should attend
Programme highlights
View full programme- Tue, 1 Dec 2026Morning Workshop: Moving Beyond CD19 to Identify the Next-Generation of Clinically Viable TargetsWorkshop2 sessions this day
- Wed, 2 Dec 2026Chair’s Opening Remarks – From Promise to Reality: Advancing Cell Therapies Beyond OncologyPlenary14 sessions this day
- Thu, 3 Dec 2026Chair’s Opening RemarksPlenary13 sessions this day
Keynote speakers
View programmeKeynote
President & Chief Executive Officer, Artiva Biotherapeutics, Inc
Deep B-Cell Depletion: Evolution From Early Proof-of-Concept To Registrational TrialsKeynote
Executive Director, Preclinical Development, Moderna
Advancing In Vivo CAR-T Platforms from Preclinical Development to Clinical Translation
Speakers
View all 23 speakersArtiva Biotherapeutics, Inc
Can Cell Therapy Be Adopted Broadly in the Community Setting?
Organiser and contact
Contact
- Event secretary:
- Juliana Schulte
- Email:
- [email protected]
Advertisement
Related events
- 8th CNS Drug Delivery SummitBoston, United States of America1–3 Dec 2026
- 10th Antifibrotic Drug Development Summit 2026Boston, United States of America1–3 Dec 2026
- LEAP HR: Emerging Biopharma 2026Boston, United States of America7–9 Dec 2026
- 10th Complement-Based Drug Development SummitBoston, United States of America8–10 Dec 2026
- BIO Partnering @JPM Week 2027San Francisco, United States of America11–14 Jan 2027
- BIO International Convention 2027Philadelphia, United States of America7–10 Jun 2027